Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / May / Ocugen GA Trial Advances Toward Phase 3
Practice Management Opinions Business and Entrepreneurship

Ocugen GA Trial Advances Toward Phase 3

Ocugen reports positive Phase 2 data for its OCU410 gene therapy in geographic atrophy

5/1/2026 1 min read

Share

  • Full Article
  • Summary
  • Listen
  • Quiz
  • Top Institutions
Top Institutions in Ophthalmology

Institutions were ranked based on their involvement in the Ocugen OCU410 geographic atrophy program, including clinical trial participation, research output, and overall reputation in ophthalmology.

  • #1

    Duke University Eye Center

    Durham, NC

    Duke has a strong focus on gene therapy and surgical retina programs, with significant contributions to the OCU410 program and a top-10 national ranking in ophthalmology.

    Key Differentiators

    • Ophthalmology
  • #2

    UPMC Vision Institute

    Pittsburgh, PA

    UPMC is recognized for its advanced imaging and artificial intelligence research in macular diseases, actively participating in OCU410 trials.

    Key Differentiators

    • Ophthalmology
  • #3

    Wills Eye Hospital / Mid Atlantic Retina

    Philadelphia, PA

    Wills Eye Hospital has a high-volume retina service and extensive experience in conducting geographic atrophy trials.

    Key Differentiators

    • Ophthalmology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: